GGrantIndex
Sort

34,240 grants matching atherosclerosis

Characterization of Coagulation Factor-platelet Interactions: Role of FXI

$695,571
Owen J McCarty · Oregon Health & Science University · R01 · FY2020 · HL

Epidemiology of CHD of men aged 40+ in US, Hawaii, Japan

$695,553
Akira Sekikawa · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · HL

Using genomics and functional biology to understand fibrinogen and its effect on thrombotic and atherosclerotic outcomes

$695,502
Alanna C Morrison · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · HL

Novel Regulators of Calcific Aortic Valve Disease

$695,452
Mehran M Sadeghi · Yale University · R01 · FY2019 · HL

Project 1: Endothelial cell programs for coronary artery disease

$695,419
Rajat M Gupta · Stanford University · P01 · FY2025 · HL

Air Pollution, Intima-media Thickness, and Lung Function in College Students

$695,411
Edward Avol · University Of Southern California · R01 · FY2006 · ES

ANGPTL3 DEFICIENCY AND ATHEROSCLEROSIS IN HUMANS

$695,363
Nathan Oliver Stitziel · Washington University · R01 · FY2016 · HL

Multi-Scale Biology of Atherosclerosis in the Cellular Adhesion Pathway

$695,311
Suzette Janine Bielinski · Mayo Clinic Rochester · R01 · FY2014 · HL

Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta

$695,285
Alexander Egbe · Mayo Clinic Rochester · R01 · FY2023 · HL

A Novel PAI-1 Function Drives Lung Fibrosis

$695,226
Thomas H Sisson · University Of Michigan At Ann Arbor · R01 · FY2024 · HL

Integrated prediction of cardiovascular events by automated coronary plaque and pericoronary adipose tissue quantification from CT Angiography

$695,211
Damini Dey · Cedars-Sinai Medical Center · R01 · FY2022 · HL

Integrated prediction of cardiovascular events by automated coronary plaque and pericoronary adipose tissue quantification from CT Angiography

$695,211
Damini Dey · Cedars-Sinai Medical Center · R01 · FY2023 · HL

Experimental Pathology of Cardiovascular Disease

$695,109
University Of Washington · T32 · FY2004 · HL

Improving Lipid Management Strategies in Young Adults

$695,047
Yiyi Zhang · Columbia University Health Sciences · R01 · FY2025 · HL

Neutrophil Development During Inflammation and Atherosclerosis

$695,031
Catherine C Hedrick · Scripps Research Institute, The · P01 · FY2024 · HL

The role of irregular sleep schedules as a ubiquitous marker of chronic circadian disruption in cardiometabolic disease development

$695,016
Tianyi Huang · Brigham And Women'S Hospital · R01 · FY2022 · HL

Biogenesis of the endoplasmic reticulum

$694,864
William Prinz · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK

Experimental Pathology of Cardiovascular Disease

$694,820
Stephen Mark Schwartz · University Of Washington · T32 · FY2016 · HL

New therapeutic approaches in clonal hematopoiesis and atherosclerosis

$694,718
Alan Richard Tall · Columbia University Health Sciences · R01 · FY2023 · HL

Longitudinal Study of HIV and Aging in Brazil

$694,692
Jessica L Castilho · Vanderbilt University Medical Center · R01 · FY2023 · AG

EPIDEMIOLOGY OF AGE RELATED OCULAR DISEASE

$694,587
University Of Wisconsin Madison · U10 · FY2000 · EY

Copper transport protein and inflammatory angiogenesis

$694,559
Tohru Fukai · University Of Illinois At Chicago · R01 · FY2013 · HL

Gene regulatory networks controlling smooth muscle phenotype and vasculardisease risk

$694,555
Thomas None Quertermous · Stanford University · R01 · FY2024 · HL

Characterization of Coagulation Factor-platelet Interactions: Role of FXI

$694,550
Owen J McCarty · Oregon Health & Science University · R01 · FY2024 · HL

Proteomic determinants of direct measures of insulin sensitivity

$694,532
Themistocles Leonard Assimes · Stanford University · R01 · FY2021 · DK